Patients with vivax malaria who have glucose-6-phosphate dehydrogenase (G6PD) deficiency, an inherited enzymopathy, are at risk of drug-induced haemolysis when taking either primaquine or tafenoquine. The gene discussed is G6PD; the disease is Plasmodium vivax malaria.